help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, J.
Right arrow Articles by Bondy, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, J.
Right arrow Articles by Bondy, C.
Endocrinology Vol. 140, No. 7 3391-3394
Copyright © 1999 by The Endocrine Society


ARTICLES

Effects of Igf1 Gene Deletion on Postnatal Growth Patterns

Jie Wang, Jian Zhou, Lynn Powell-Braxton and Carolyn Bondy

Developmental Endocrinology Branch (J.W., J.Z., C.B.), NICHD, NIH, Bethesda, Maryland 20892; Cardiovascular Research Department (L.P.-B.), Genentech Inc., San Francisco, California

Address all correspondence and requests for reprints to: Carolyn Bondy, M.D., NIH, 10 Center Drive, Building 10, Room 10N 262, Bethesda, Maryland 20892.


    Abstract
 Top
 Abstract
 
This study documents the temporal and organ-specific effects of Igf1 gene deletion on postnatal growth patterns. Igf1-/- mice are 63 ± 4% the size of wildtype (wt) littermates at birth and this ratio persists through postnatal day 20 (P20). After P20, Igf1-/- mice virtually stop growing, while wt littermates double in size from P20 to P40, after which their growth markedly decelerates. As a result, ‘full-grown’ Igf1-/- mice are less than one third the size of wt littermates. Igf1 gene deletion has disproportionate effects on organ growth. For example, at P10 and P40, Igf1-/- body weights are 63% and 31% of wt,respectively, while Igf1-/- lungs weigh only 34% and 22% of wt at these ages. In contrast, the Igf1-/-heart is disproportionately enlarged, representing ~85% of wt at P10 and ~56% at P40. Igf1-/- kidney, spleen and liver are slightly but significantly increased in size relative to the degree of reduction in Igf1-/- body weight. These data demonstrate that Igf1 has two major phases or modes of growth promotion. There is an early, growth hormone (GH)-independent Igf1 growth augmentation during perinatal development, responsible for about 35% of growth prior to P20. Then there are later effects due to GH-induced Igf1, which are responsible for increasing animal size by ~100% between P20 and 40. The fact that there is virtually no GH-induced growth in the Igf1-/- mice supports the view that Igf1 mediates GH’s major effects on somatic growth. Finally, this study shows that Igf1-/- has discordant effects on pulmonary and cardiac growth parameters, with relative hypoplasia of Igf1-/-lungs and hypertrophy of Igf1-/- hearts.

Received March 4, 1999.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
J. van den Berg, E. M. N. Bannink, P. A. Wielopolski, W. C. J. Hop, L. van Osch-Gevers, P. M. T. Pattynama, S. M. P. F. de Muinck Keizer-Schrama, and W. A. Helbing
Cardiac Status after Childhood Growth Hormone Treatment of Turner Syndrome
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2553 - 2558.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. Stoffel, B. Jenke, B. Holz, E. Binczek, R. H. Gunter, J. Knifka, J. Koebke, and A. Niehoff
Neutral Sphingomyelinase (SMPD3) Deficiency Causes a Novel Form of Chondrodysplasia and Dwarfism That Is Rescued by Col2A1-Driven smpd3 Transgene Expression
Am. J. Pathol., July 1, 2007; 171(1): 153 - 161.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. J. Frank
Growth Hormone, Insulin-Like Growth Factor I, and Growth: Local Knowledge
Endocrinology, April 1, 2007; 148(4): 1486 - 1488.
[Full Text] [PDF]


Home page
EndocrinologyHome page
C. Moerth, M. R. Schneider, I. Renner-Mueller, A. Blutke, M. W. Elmlinger, R. G. Erben, C. Camacho-Hubner, A. Hoeflich, and E. Wolf
Postnatally Elevated Levels of Insulin-Like Growth Factor (IGF)-II Fail to Rescue the Dwarfism of IGF-I-Deficient Mice except Kidney Weight
Endocrinology, January 1, 2007; 148(1): 441 - 451.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Ning, A. G. P. Schuller, S. Bradshaw, P. Rotwein, T. Ludwig, J. Frystyk, and J. E. Pintar
Diminished Growth and Enhanced Glucose Metabolism in Triple Knockout Mice Containing Mutations of Insulin-Like Growth Factor Binding Protein-3, -4, and -5
Mol. Endocrinol., September 1, 2006; 20(9): 2173 - 2186.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
M. E. Davis and R. C. M. Simmen
Genetic parameter estimates for serum insulin-like growth factor I concentrations, and body weight and weight gains in Angus beef cattle divergently selected for serum insulin-like growth factor I concentration
J Anim Sci, September 1, 2006; 84(9): 2299 - 2308.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. M. Cheng, V. Tseng, J. Wang, D. Wang, L. Matyakhina, and C. A. Bondy
Tau Is Hyperphosphorylated in the Insulin-Like Growth Factor-I Null Brain
Endocrinology, December 1, 2005; 146(12): 5086 - 5091.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Mazerbourg, D. M. Bouley, S. Sudo, C. A. Klein, J. V. Zhang, K. Kawamura, L. V. Goodrich, H. Rayburn, M. Tessier-Lavigne, and A. J. W. Hsueh
Leucine-Rich Repeat-Containing, G Protein-Coupled Receptor 4 Null Mice Exhibit Intrauterine Growth Retardation Associated with Embryonic and Perinatal Lethality
Mol. Endocrinol., September 1, 2004; 18(9): 2241 - 2254.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Huang, S.-O. Kim, N. Yang, J. Jiang, and S. J. Frank
Physical and Functional Interaction of Growth Hormone and Insulin-Like Growth Factor-I Signaling Elements
Mol. Endocrinol., June 1, 2004; 18(6): 1471 - 1485.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Michael, S. Haq, X. Chen, E. Hsich, L. Cui, B. Walters, Z. Shao, K. Bhattacharya, H. Kilter, G. Huggins, et al.
Glycogen Synthase Kinase-3{beta} Regulates Growth, Calcium Homeostasis, and Diastolic Function in the Heart
J. Biol. Chem., May 14, 2004; 279(20): 21383 - 21393.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. A. M. Salih, G. Tripathi, C. Holding, T. A. M. Szestak, M. I. Gonzalez, E. J. Carter, L. J. Cobb, J. E. Eisemann, and J. M. Pell
Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice
PNAS, March 23, 2004; 101(12): 4314 - 4319.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Colao, D. Ferone, P. Marzullo, and G. Lombardi
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
Endocr. Rev., February 1, 2004; 25(1): 102 - 152.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Li, K. Iida, J. O'Neil, P. Zhang, S.'a. Li, A. Frank, A. Gabai, F. Zambito, S.-H. Liang, C. J. Rosen, et al.
PERK eIF2{alpha} Kinase Regulates Neonatal Growth by Controlling the Expression of Circulating Insulin-Like Growth Factor-I Derived from the Liver
Endocrinology, August 1, 2003; 144(8): 3505 - 3513.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Shiojima, M. Yefremashvili, Z. Luo, Y. Kureishi, A. Takahashi, J. Tao, A. Rosenzweig, C. R. Kahn, E. D. Abel, and K. Walsh
Akt Signaling Mediates Postnatal Heart Growth in Response to Insulin and Nutritional Status
J. Biol. Chem., September 27, 2002; 277(40): 37670 - 37677.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Holzenberger, G. Hamard, R. Zaoui, P. Leneuve, B. Ducos, C. Beccavin, L. Perin, and Y. Le Bouc
Experimental IGF-I Receptor Deficiency Generates a Sexually Dimorphic Pattern of Organ-Specific Growth Deficits in Mice, Affecting Fat Tissue in Particular
Endocrinology, October 1, 2001; 142(10): 4469 - 4478.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Camarero, C. Avendano, C. Fernandez-Moreno, A. Villar, J. Contreras, F. de Pablo, J. G. Pichel, and I. Varela-Nieto
Delayed Inner Ear Maturation and Neuronal Loss in Postnatal Igf-1-Deficient Mice
J. Neurosci., October 1, 2001; 21(19): 7630 - 7641.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Fruchtman, L. Jackson, and R. Borski
Insulin-Like Growth Factor I Disparately Regulates Prolactin and Growth Hormone Synthesis and Secretion: Studies Using the Teleost Pituitary Model
Endocrinology, August 1, 2000; 141(8): 2886 - 2894.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Holzenberger, P. Leneuve, G. Hamard, B. Ducos, L. Perin, M. Binoux, and Y. Le Bouc
A Targeted Partial Invalidation of the Insulin-Like Growth Factor I Receptor Gene in Mice Causes a Postnatal Growth Deficit
Endocrinology, July 1, 2000; 141(7): 2557 - 2566.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. J. Borski, W. Tsai, R. Demott-Friberg, and A. L. Barkan
Induction of growth hormone (GH) mRNA by pulsatile GH-releasing hormone in rats is pattern specific
Am J Physiol Endocrinol Metab, May 1, 2000; 278(5): E885 - E891.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J.-L. Liu, S. Yakar, and D. LeRoith
Conditional Knockout of Mouse Insulin-Like Growth Factor-1 Gene Using the Cre/loxP System
Experimental Biology and Medicine, April 1, 2000; 223(4): 344 - 351.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. M. Pell, R. A. Hill, C. E. H. Stewart, C. R. Weston, and H. C. Flick-Smith
Enhancement of Insulin-Like Growth Factor I Activity by Novel Antisera: Potential Structure/Function Interactions
Endocrinology, February 1, 2000; 141(2): 741 - 751.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J.-L. Liu and D. LeRoith
Insulin-Like Growth Factor I Is Essential for Postnatal Growth in Response to Growth Hormone
Endocrinology, November 1, 1999; 140(11): 5178 - 5184.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. Lu, G. Schwartzbauer, M. A. Sperling, S. U. Devaskar, S. Thamotharan, P. D. Robbins, C. F. McTiernan, J.-L. Liu, J. Jiang, S. J. Frank, et al.
Demonstration of Direct Effects of Growth Hormone on Neonatal Cardiomyocytes
J. Biol. Chem., June 15, 2001; 276(25): 22892 - 22900.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, J.
Right arrow Articles by Bondy, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, J.
Right arrow Articles by Bondy, C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals